On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Aberrant glycosylation is an oncogenesis hallmark
- Cell transformation & glycoconjugate biosynthesis
- Aberrant glycosylation & blood group expression
- Study by Hajime Masamune
- Cancer and healthy cells show difference in lectin
- Cancer glycosignatures in transformed cells
- Human and mouse glycan-related genes
- Small sample of glycosyltransferase reactions
- Alteration of glycan expression
- Understanding altered glycans during oncogenesis
- Glycan changes in breast cancer
- Aberrant N-glycan branching during oncogenesis
- The N-linked glycan synthesized by GnT-V
- L-PHA binding to breast tissue sections
- The signaling pathway of GnT-V expression
- GnT-V up-regulation in cancer tissues
- GnT-V expression levels regulate cell-cell adhesion
- Glycan-driven feedback amplification loop
- GnT-V is a multi-function controller
- GnT-V deletion delayed her-2-induced tumor onset
- GnT-V deletion reduced tumor initiating cells (TIC)
- Identifying potential biomarkers of breast cancer
- Depicting targeted glycoproteomics with L-PHA
- Identification of GnT-V products in tissue extracts
- Tumor-specific glycoproteins bound to L-PHA
- Information on the glycoprotein periostin
- Recent data on periostin and cancer stem cells
- Glycosyltransferase loss in oncogenesis
- Tn and sialyl Tn antigens cell surface expression
- Overview of Tn & STn expression in human cancer
- O-glycan structures
- Biosynthesis of O-glycans
- Cosmc - a specific chaperone of T-synthase
- Dysfunctional Cosmc & Tn and sialyl Tn antigens
- Effects of loss of T-synthase
- Acknowledgements
- References (1)
- References (2)
- References (3)
Topics Covered
- Glycomics
- Tumor-specific glycoproteins
- Aberrant glycosylation
- Understanding altered glycans during oncogenesis
- Glycosyltransferase
- GnT-V in oncogenesis
- L-PHA in cancer
- Tn and sialyl Tn antigens
- O-glycan structures
- Dysfunctional Cosmc
- Loss of T-synthase
- Overexpression of Periostin
Talk Citation
Pierce, M. (2012, November 27). Glycosylation changes during oncogenesis [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/PIER7487.Export Citation (RIS)
Publication History
- Published on November 27, 2012
Financial Disclosures
- Prof. Michael Pierce has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.